Regen BioPharma Inc (RGBP)

[Skiluc]

Edited. NR2F6 is becoming a leading mRNA study and Regen owns and controls most every aspect of NR2F6, including controllable reactions, via USPTO protections via patents and patent applications.

What if someone crossed one of our protections? What if its someone significant? After all mRNA and NR2F6 are both exploding! What if one of these companies advancing NR2F6 starts testing 70,000 molecule/compounds to learn that Regen already has… with Eli Lilly and Company. And then Patented every single molecule/compounds having any reaction, while Eli Lilly holds the molecule/compunds rights. Oh… but there is more. We learned and also patented specifically the ones having significant controlled reactions. Many of which made it thru Toxicity trials!!

Thats right. Regen owns molecule/compounds that significantly control NR2F6. Let that sink in folks as you do your DD. Pinned posts above good plce to start.

Patents are one thing. Thousands of lab hours backing patents is an entirely other. Working IP at Regen is Undeniable.

NR2F6 has been mostly unknown or abstract science… until very recently, and Dr Koos was early. And nailed it! The partnerships and Collaborative history is Undeniable. Who is Dr. Santosh Kesari? And Now, by third party verification, NR2F6 appears to be THE significant receptor with most all tumorus cancer.

Its a busy day. But perhaps i can YET AGAIN, put all the NR2F6 data together later this week.

Two things are Undeniable. New and revealing studies around NR2F6(leading mRNA outside of Covid IMO). And the library of patents and applications in and around NR2F6.

These studies and their findings are Undeniable:

https://www.ncbi.nlm.nih.gov/gene/2063

And lets not forget our lead drug candidates:

https://www.prnewswire.com/news-releases/regen-biopharma-inc-receives-fda-clearance-to-initiate-clinical-trial-of-hemaxellerate-562342421.html

And

https://finance.yahoo.com/news/fda-issues-ind-number-regen-133000835.html